Cedars-Sinai physician-scientists joined peers from around the world at the Alzheimer's Association International Conference ...

A Shropshire charity says it is ready to start clinical trials on a new drug to treat lung cancer. Although the charity ...

It is vital that clinical trials for patients with cancer shift to a more representative approach to accurately reflect ...

A novel drug, evenamide, quieted overactive brain circuits in an animal model of schizophrenia, improving memory, social ...

Novartis announces both ianalumab phase III trials meets primary endpoint in patients with Sjögren’s disease: Basel Tuesday, August 12, 2025, 14:00 Hrs [IST] Novartis announced ...

Private equity investor Gresham House Ventures has sold its stake in clinical trials business Panthera Biopartners to LDC, ...

Jon Walsh, founder, chief scientific officer, Unlearn, explains how regulators are clarifying best practices for integrating AI and digital twins into clinical research.

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

Breaking Down the Clinical Trial Process Clinical trials are the backbone of modern oncology, often determining the most effective primary treatment for various types of cancer. They’re the ...

Clinical trial innovation is a hot topic, but it’s not a new one. The first fully virtual randomized trial was conducted more than a decade ago. [1] Drug developers have long recognized the need ...

A UCSF team develops a new drug for malaria that could address one of the disease's biggest challenges - the spread of parasites that resist the most commonly-used medications.

MASH clinical trials test treatments for metabolic dysfunction-associated steatohepatitis, focusing on reversing liver inflammation, fibrosis, and fat accumulation safely.